← Back to Search

Electrodesiccation and Curettage vs Excision for Skin Surgery

N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-12 months
Awards & highlights

Summary

This trial compares two methods for treating low-risk skin lesions on the body: scraping off the lesion with electric current versus cutting it out and stitching the wound. The study aims to see which method results in a better-looking scar and how it affects patients' quality of life. Electrosurgery is a well-established method for treating skin lesions, offering advantages such as rapid treatment and cosmetically acceptable results.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Scar Assessment
Secondary study objectives
Complications
Quality of Life Measures (DLQI)

Trial Design

2Treatment groups
Experimental Treatment
Group I: ExcisionExperimental Treatment1 Intervention
The excision arm will undergo standard excision with repair by complex linear closure.
Group II: ED&CExperimental Treatment1 Intervention
The ED\&C arm will receive the standard ED\&C care.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
928 Previous Clinical Trials
4,720,959 Total Patients Enrolled

Media Library

Electrodesiccation and Curettage Clinical Trial Eligibility Overview. Trial Name: NCT05074225 — N/A
Skin Surgery Research Study Groups: ED&C, Excision
Skin Surgery Clinical Trial 2023: Electrodesiccation and Curettage Highlights & Side Effects. Trial Name: NCT05074225 — N/A
Electrodesiccation and Curettage 2023 Treatment Timeline for Medical Study. Trial Name: NCT05074225 — N/A
~11 spots leftby Sep 2025